A trial to study the effect of dendritic cells vaccine combined with nivolumab for the treatment of patients with advanced pancreatic cancer
Latest Information Update: 15 Jul 2016
Price :
$35 *
At a glance
- Drugs Dendritic cell vaccines (Primary) ; Nivolumab (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 15 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology